The UK’s drugs regulator—the MHRA—has approved the Alzheimer’s drug donanemab, but it won’t be available on the NHS.
This article was originally published on MedicalXpress.com
Alzheimer’s drug approved in the UK, but it won’t be available on the NHS—here’s why
You may also be interested in:
The Latest
Avoiding Common Relationship Mistakes for a Happier Love Life
Fostering a rewarding and fulfilling relationship is no easy task. You and your partner are only human, and, as the saying goes, you are going to make mistakes. However, learning the common relationship mistakes and […]
The Latest
5 Popular Supplements in Canada for Optimal Health and Wellness
As a health and wellness enthusiast, I have always been interested in the role of supplements in promoting optimal health. In Canada, there are many supplements available on the market, each with different benefits and […]
The Latest
Why you should stop buying vitamins and get more sleep instead
Almost half of all Canadians regularly take at least one nutritional supplement such as vitamins, minerals, fibre supplements, antacids and fish oils. Many of these individuals are healthy and hoping to improve general well-being or prevent chronic […]
Read More:
-
More children are overweight in regions with high rates of single parenthood, low education levels, low income and high child poverty. The pandemic may also [...]
-
A unique study has thrown new light on how young children begin to understand the meaning of words. The findings by the researchers from the [...]
-
In 2025, children within the TEDDY study will submit their final samples at research clinics in Sweden, Finland, Germany and the United States. The international [...]
